Aug 28 (Reuters) - Cooper Companies ( COO ) beat Wall

Street revenue estimates for the third quarter on Wednesday and

lifted its annual forecast, betting on demand for its contact

lenses.

Shares of the medical device maker rose 4.19% to $98.50,

after the bell.

The increased adoption of daily disposable lenses has led to

supply constraints within the industry, even as Cooper

experiences strong demand.

Peer Alcon reported a smaller-than-expected

increase in second-quarter sales last week, hit by weak

performance in its business units and adverse currency exchange

effects.

CooperVision, the company's contact lens division, reported

quarterly sales of $675.6 million, surpassing analysts'

expectations of $670.62 million, according to LSEG data.

Sales of the company's surgical division, which specializes

in fertility and and women's care devices, increased by 9% to

$327.2 million in the quarter, above estimates of $326.95

million.

Cooper sees its annual adjusted profit per share to be in

the range of $3.64 to $3.67, higher than $3.54 to $3.60 it

previously expected.

For the fiscal 2024, the company sees its revenue to be

between $3.89 billion and $3.91 billion.

Analysts on average expect the company to report a

revenue of $3.89 billion and a profit of $3.57 per share for

2024.

The company posted total revenue of $1 billion, for the

quarter ended July 31, beating analysts' estimate of $997.30

million.

On an adjusted basis, the company reported a profit of 96

cents, ahead of analysts' expectations of 91 cents.